150 related articles for article (PubMed ID: 38678422)
1. Detection of metallo-beta-lactamase-producing genes
Monteagudo de Barros V; da Rocha BS; Rhoden J; Stein JF; Picoli SU; Rigotto C
J Water Health; 2024 Apr; 22(4):689-700. PubMed ID: 38678422
[No Abstract] [Full Text] [Related]
2. [Molecular Analysis of Antibiotic Resistance in CarbapenemResistant Pseudomonas aeruginosa Isolates Isolated from Clinical Samples].
Altan G; Rakici E; Özgümüş OB
Mikrobiyol Bul; 2024 Apr; 58(2):148-170. PubMed ID: 38676583
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.
Meletiadis J; Paranos P; Georgiou PC; Vourli S; Antonopoulou S; Michelaki A; Vagiakou E; Pournaras S
Int J Antimicrob Agents; 2021 Nov; 58(5):106440. PubMed ID: 34551356
[TBL] [Abstract][Full Text] [Related]
4. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
5. Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance.
Diorio-Toth L; Irum S; Potter RF; Wallace MA; Arslan M; Munir T; Andleeb S; Burnham CD; Dantas G
Microbiol Spectr; 2022 Jun; 10(3):e0076622. PubMed ID: 35638817
[TBL] [Abstract][Full Text] [Related]
6. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
7. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
[TBL] [Abstract][Full Text] [Related]
8. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
[TBL] [Abstract][Full Text] [Related]
9. Genomic insights into NDM-1-producing Pseudomonas aeruginosa: Current status in a Bulgarian tertiary hospital and on the Balkans.
Strateva T; Keuleyan E; Peykov S
Acta Microbiol Immunol Hung; 2024 Jul; 71(2):99-109. PubMed ID: 38857113
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime-avibactam and ceftolozane-tazobactam susceptibility of multidrug resistant Pseudomonas aeruginosa strains in Hungary.
O'Neall D; Juhász E; Tóth Á; Urbán E; Szabó J; Melegh S; Katona K; Kristóf K
Acta Microbiol Immunol Hung; 2020 Mar; 67(1):61-65. PubMed ID: 32208923
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021.
Lee YL; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2023 Aug; 62(2):106867. PubMed ID: 37244423
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Piérard D; Stone GG
BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection of Metallo-Beta-Lactamase and alginate in multidrug resistance
Qader GM; Jarjees KK; Jarjees RK
J Med Life; 2022 Sep; 15(9):1105-1109. PubMed ID: 36415531
[No Abstract] [Full Text] [Related]
14. Molecular characterization of NDM-1-producing Pseudomonas aeruginosa isolates from hospitalized patients in Iran.
Shahin M; Ahmadi A
Ann Clin Microbiol Antimicrob; 2021 Nov; 20(1):76. PubMed ID: 34732199
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Martins AF; Zavascki AP; Gaspareto PB; Barth AL
Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the resistance mechanism and homology of carbapenems-resistant Pseudomonas aeruginosa].
Liu Y; Deng Q; Yu Y; Cao X; Xu Q; Wan L
Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):15-20. PubMed ID: 24684984
[TBL] [Abstract][Full Text] [Related]
17. Identification and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran, Iran.
Shahcheraghi F; Nikbin VS; Feizabadi MM
New Microbiol; 2010 Jul; 33(3):243-8. PubMed ID: 20954442
[TBL] [Abstract][Full Text] [Related]
18. Evaluated gene expressions of Metallo beta lactamase genes GIM and , VIM, SPM in Pseudomonas aeruginosa clinical isolates.
Ali MG; Almoneim ZA; Kareem SM
Mol Biol Rep; 2023 Dec; 50(12):10111-10120. PubMed ID: 37917414
[TBL] [Abstract][Full Text] [Related]
19. Genotypic characteristics of multidrug-resistant Pseudomonas aeruginosa from hospital wastewater treatment plant in Rio de Janeiro, Brazil.
Miranda CC; de Filippis I; Pinto LH; Coelho-Souza T; Bianco K; Cacci LC; Picão RC; Clementino MM
J Appl Microbiol; 2015 Jun; 118(6):1276-86. PubMed ID: 25752460
[TBL] [Abstract][Full Text] [Related]
20. Hospital wastewater as source of human pathogenic bacteria: A phenotypic and genomic analysis of international high-risk clone VIM-2-producing Pseudomonas aeruginosa ST235/O11.
Zagui GS; de Almeida OGG; Moreira NC; Silva NGA; Meschede MSC; Darini ALC; Andrade LN; Segura-Muñoz SI
Environ Res; 2024 Aug; 255():119166. PubMed ID: 38759772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
